Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PETHEMA LAL-07FRAIL Protocol for Frail Elderly Ph- Negative ALL
NCT01358201Phase 4Unknown
- Sponsor
- Fundación PETHEMA
- Start
- May 2010
- Primary completion
- Dec 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vincristine, dexamethasone, methotrexate, cytarabine, mercaptopurine in acute lymphoblastic leukemia (ALL), sponsored by Fundación PETHEMA. Status: unknown.
02
Drugs
vincristinedexamethasonemethotrexatecytarabinemercaptopurine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01358201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01358201.